Next Up

Biomarkers US: In-Person

03 - 04 October 2022 |

San Diego, USA

03 - 04 October 2022

San Diego, USA

+ Digital Day: 05 October 2022 | Online

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Nov 2022
November 2022

Biomarker Analysis Europe: In-Person

Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis

03 Nov 2022
Thu, 03 November 2022

Clinical and Translational Biomarkers: Online

07 Dec 2022
Wed, 07 December 2022

Biomarkers for NASH Symposium

Designed to deliver the latest insights on advancing NASH therapeutic development and diagnosis through non-invasive biomarker strategies

Highlights

Immunotherapy Biomarkers
Insight Article
From maximising immune response with combination biomarkers to conducting diagnostic innovation in immunotherapy prognosis, the future of predictive biomarkers is fast approaching. We speak to senior representatives from industry and academia to find out more.
By Tia Byer |
16 May 2022
Biomarkers for Drug Discovery & Development
Insight Article
By Tia Byer |
29 Apr 2022
Biomarkers for Clinical Development
Discussion Group Report
By Tia Byer |
26 Apr 2022
Biomarkers for Clinical Development

In-Depth

Insight Article
From maximising immune response with combination biomarkers to conducting diagnostic innovation in immunotherapy prognosis, the future of predictive biomarkers is fast approaching. We speak to senior representatives from industry and academia to find out more.
16 May 2022
Insight Article
Key opinion leaders from GlaxoSmithKline and Weill Cornell Medicine discuss future perspectives on neuro-organoids.
29 April 2022
Discussion Group Report
Jordi Clarimon, Lead Specialist in Fluid Biomarkers at Lundbeck, leads a discussion on ‘Fluid Biomarkers for Neurodegenerative Diseases.
26 April 2022
Commentary
In this Commentary article, we investigate the applications of human stem cell modelling for identifying the ways in which neurodegenerative diseases such as Alzheimer's and Parkinson's affect the brain.
08 April 2022

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biomarkers